Alembic Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP

Key managerial personnel resignedManagement Changes View source PDF Explain this filing

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹785.00

prior close

₹793.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.4%-0.2% vs market

Pharmaceuticals peers, median of 160sector-0.1%-0.4% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-1.9

15m

-1.9

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5-0.4-0.2-0.1-0.4

Next day

-7.5-1.7-5.8-0.9-6.7

-4.1-1.3-2.8-0.2-3.9

-4.5-0.7-3.8+0.3-4.8

-4.6+0.4-5.0+1.1-5.7

-3.6+0.5-4.1+0.2-3.8

-3.3+2.8-6.1+1.0-4.3

15d

-4.9+1.2-6.1-0.2-4.7

-5.9+5.3-11.2+1.7-7.6

+8.6+9.9-1.3+7.7+0.9

+4.9+13.1-8.2+8.1-3.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alembic Pharmaceuticals has disclosed the resignation of Mr. Rohit Garg, Senior Vice President – Strategy & Business Excellence. He submitted his resignation on March 17, 2026, citing personal reasons. His last working day will be May 15, 2026. Rohit cited an over 5-year tenure with the company and thanked the organization for its support during his stint.

Likely market impact

The departure of a senior-level KMP may raise concerns about continuity in strategic leadership, especially in a key growth function. Investors should monitor for any operational disruption or replacement announcement.